Skip to main content
. 2021 Jul 6;197(11):1010–1020. doi: 10.1007/s00066-021-01803-3

Table 1.

Clinical characteristics of patients with COVID-19 treated with low-dose radiation therapy

Variables (n=36)
Age 83.64 (8.11)b
Sex
Female 17 (47.2)a
Male 19 (52.8)
Neurologic diseases 10 (27.8)b
Cardiovascular diseases 30 (83.3)b
Respiratory diseases 12 (33.3)b
Other comorbidities 31 (86.1)b
Days with symptoms 5.72 (1.54)b
Functional status (Barthel Index)
Independent 6 (16.7)a
Minimally dependent 12 (33.3)
Partially dependent 7 (19.4)
Very dependent 8 (22.2)
Total dependent 3 (8.3)
Geriatric Depression Scale (GDS)
No cognitive decline 18 (50)a
Very mild cognitive decline 8 (22.2)
Mild cognitive decline 5 (13.9)
Moderate cognitive decline
Moderately severe cognitive decline 2 (5.6)
Severe cognitive decline 3 (8.3)
Very severe cognitive decline
Pharmacological treatment
Corticosteroids (dexamethasone) 36 (100)a
Remdesivir 2 (5.6)
Tocelizumab 2 (5.6)
Basal SpO2 94.28 (2.85)b
Basal SaFi 255.42 (117.75)b
Mild 18 (50)a
Moderate 5 (13.9)
Severe 13 (36.1)
Basal PaFi 251.39 (128.19)b
Mild 25 (69.4)a
Moderate 4 (11.1)
Severe 7 (19.4)
CURB-65 Score
1 points
2 points 10 (27.8)a
3 points 17 (47.2)
4 points 9 (25)
CT lung involvement (%)
< 5%
5–25% 1 (2.8)a
26–50% 7 (19.4)
51–75% 18 (50)
> 75% 10 (27.8)
Final status
Alive 23 (63.9)a
Death due to COVID-19 8 (22.2)
Death due to other causes 5 (13.9)

CT Computed Tomography; CURB-65 validated clinical prediction score for predicting mortality in community-acquired pneumonia and infection of any site including measurement of: Confusion of new onset, Blood Urea Nitrogen, Respiratory rate, Blood pressure and Age; PaFi ratio of arterial oxygen partial pressure (PaO2) to Fractional Inspired Oxygen (FiO2); SpO2 oxygen saturation; SaFi ratio of SpO2 to FiO2

aResults shown as frequencies and percentages in parenthesis

bResults shown as means and standard deviations in parenthesis